Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company - David Cavalla - cover

Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company

David Cavalla

0 recensioni
Con la tua recensione raccogli punti Premium
pagabile con 18App pagabile con Carta del Docente
Articolo acquistabile con 18App e Carta del Docente
Anno: 1997
Rilegatura: Hardback
Pagine: 228 p.
Testo in English
Dimensioni: 234 x 150 mm
Peso: 456 gr.
  • EAN: 9780471971177

€ 195,30

€ 210,00
(-7%)

Punti Premium: 195

Venduto e spedito da IBS

Quantità:
LIBRO INGLESE
Gaia la libraia

Gaia la libraia Vuoi ricevere un'email sui tuoi prodotti preferiti? Chiedi a Gaia, la tua assistente personale

The twentieth century has been a great success for modern medicine, and has resulted in the generation of a plethora of drugs to treat most common illnesses. However, in the light of increasing regulatory demands, spiralling costs and diminishing commercial returns, the question of how, when, where and whether to conduct pharmaceutical R&D has profound implications, and not just for those within the pharmaceutical industry. In response to these and other dilemmas, the authors define the processes involved in drug research, and examine the advantages and disadvantages of collaborative methods of drug research, and examine the roles that academia, CROs, small "biotechnology" companies and "research boutiques," and possibly even the "virtual research company" might play as contractors and collaborators.
Gaia la libraia

Gaia la libraia Vuoi ricevere un'email sui tuoi prodotti preferiti? Chiedi a Gaia, la tua assistente personale

Note legali